Skip to main content

Day: February 7, 2025

Endeavour to announce its Q4 and FY-2024 results on 6 March 2025

         ENDEAVOUR TO ANNOUNCE ITS Q4 AND FY-2024 RESULTS ON 6 MARCH 2025 London, 7 February 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) expects to release its Q4 and FY-2024 financial results on Thursday 6 March 2025, before the LSE market open. Management will host a conference call and webcast on the same day, Thursday 6 March, at 8:30 am EST/ 1:30 pm GMT to discuss the Company’s financial results. The conference call and webcast are scheduled at: 5:30am in Vancouver 8:30am in Toronto and New York Notice of Results1:30pm in London 9:30pm in Hong Kong and Perth The webcast can be accessed through the following link: https://edge.media-server.com/mmc/p/afpagr89 Click here to add a Webcast reminder to your Outlook Calendar. Analysts and investors are also invited to participate and ask questions by registering for...

Continue reading

Freedom Holding Corp. Reports Strong Revenue Growth in Q3 2025 Fiscal Year, Driven by Brokerage and Banking Segments

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) — Freedom Holding Corp. (NASDAQ: FRHC), a U.S.-based financial services company, has announced its financial results for the quarter ended December 31, 2024. The holding company reported a 57% increase in total revenue, with revenues reaching $655.2 million compared to $418.6 million in the same quarter of 2023. Total assets increased to $9.1 billion from $8.3 billion as of March 31, 2024. The company’s revenue has surged due to the increase of net gain on trading securities, which has risen from a $5.1 million loss to a $89.6 million gain. Additionally, company’s performance was significantly bolstered by its insurance underwriting income, which surged by 125% to $177.5 million, reflecting the expansion of pension annuities and accident insurance operations. The banking segment also demonstrated...

Continue reading

LuxUrban Hotels Inc. Announces Timing of Regular Monthly Dividend for January 2025 for Series A Cumulative Redeemable Preferred Stock

MIAMI, Feb. 07, 2025 (GLOBE NEWSWIRE) — LuxUrban Hotels Inc. (OTC: LUXH, LUXHP), which secures long-term operating rights for entire hotels through Master Lease Agreements (MLA) under which it manages the hotel and rents out, on a short-term basis, rooms to business and vacation travelers, today announced the timing for the payment of its declared regular monthly dividend of $0.2708333 per share of its 13.00% Series A Cumulative Redeemable Preferred Stock for January 2025. The dividend will be payable on February 28, 2025, to holders of record as of February 15, 2025. The dividend will be paid in cash. ABOUT LUXURBAN HOTELS INC. LuxUrban Hotels Inc. secures long-term operating rights for entire hotels through Master Lease Agreements (MLA) and rents out, on a short-term basis, hotel rooms to business and vacation travelers. The...

Continue reading

Investeringsforeningen SparDanmark Invest – Suspenderer handel med alle afdelinger

Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen om suspension af udvalgte afdelinger, som administreres af Nykredit Portefølje Administration A/S. Det skyldes, at det grundet tekniske udfordringer ikke er muligt at stille korrekt NAV.  Suspensionen vil blive ophævet, når det igen er muligt at stille korrekte priser. Følgende afdelinger er omfattet af suspensionen:Afdeling ISIN Short nameBalance DK0061530979 SDIBALKonservativ DK0061530896 SDIKONOffensiv DK0061531001 SDIOFFVækst DK0061531191 SDIVKSEventuelle spørgsmål vedrørende denne meddelelse kan rettes til Portfolio Management, npa.pm@nykredit.dk eller Christian Rye Holm, CRH@nykredit.dk.  Med venlig hilsenNykredit Portefølje Administration A/S Tage Fabrin-Brasted

Continue reading

Tenable Completes Acquisition of Vulcan Cyber

Expanded Tenable One Exposure Management Platform capabilities will unify security visibility, insight and action across the attack surface COLUMBIA, Md., Feb. 07, 2025 (GLOBE NEWSWIRE) — Tenable® Holdings, Inc., (“Tenable”) (Nasdaq: TENB) the exposure management company, today announced it has closed its acquisition of Vulcan Cyber Ltd., (“Vulcan Cyber”), a leading innovator in exposure management. Vulcan Cyber’s capabilities will enhance Tenable’s industry-leading Exposure Management platform, delivering comprehensive visibility, prioritization and remediation across the entire attack surface. “As we welcome our new team members to Tenable, we will immediately begin working on the integration process to drive expanded data insights that will better prioritize risks and simplify remediation efforts for our customers,” said Steve...

Continue reading

ServiceTitan to Announce Fiscal Fourth Quarter and Full Year Fiscal 2025 Financial Results on March 13, 2025

LOS ANGELES, Feb. 07, 2025 (GLOBE NEWSWIRE) — ServiceTitan, Inc. (Nasdaq: TTAN), the software platform that powers the trades, today announced that it will report its financial results for the fiscal fourth quarter and full year ended January 31, 2025 after market close on Thursday, March 13, 2025. In conjunction with this report, ServiceTitan will host a conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day to discuss its fiscal fourth quarter and full year fiscal 2025 financial results, as well as fiscal year 2026 outlook. ServiceTitan Fiscal Fourth Quarter and Full Year Fiscal 2025 Financial ResultsWhen: Thursday, March 13, 2025Time: 2:00 p.m. Pacific TimeOnline Registration: Registration LinkLive Access: Webcast Following completion of the events, a webcast replay will also be available at https://investors.servicetitan.com...

Continue reading

AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks

Planned Investigational New Drug application to expand on previous clinical work at the University of Alabama-Birmingham in which administration of Ampligen as an intranasal adjuvant increased immune response, including cross-protection via avian influenza antibody generation in humans OCALA, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced its initiation of a plan to advance Ampligen as a vaccine adjuvant for avian influenza as part of the Company’s antiviral priority development pipeline. AIM has engaged Amarex Clinical Research (“Amarex”), its Clinical Research Organization (“CRO”), with the application and eventual management of a follow-up Investigational New Drug (“IND”) application for the study of a potential avian influenza combination therapy of AIM’s...

Continue reading

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia ORLANDO, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) on February 3, 2025 for patent application 18/369,241, “Abuse and Misuse Deterrent Transdermal Systems” which covers its Aversa™ abuse deterrent technology. The receipt of a Notice of Allowance means that the USPTO is expected to issue a U.S. patent for this...

Continue reading

Presidio Property Trust Announces Sales of Union Town Center and Research Parkway Properties

SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) — (NASDAQ: SQFT; SQFTP; SQFTW) Presidio Property Trust, Inc. (“Presidio” or the “Company”), an internally managed, diversified real estate investment trust, today announced the sale of its Union Town Center and Research Parkway properties, comprising a multi building retail center in Colorado Springs, Colorado. “We acquired this well-located center in two separate off-market transactions in 2014 and 2015, and continued to upgrade the property and maintained occupancy close to its current 98% level,” said Gary Katz, Chief Investment Officer. “Strong interest from the capital markets for retail and the center’s location in the burgeoning north Colorado Springs region contributed to our decision to sell and successfully close out our business plan for this property.” “Continued occupancy strength...

Continue reading

Byrna Technologies Reports Record Results for Fiscal Fourth Quarter and Full Year 2024

Full-Year 2024 Revenues Reach $85.8 Million, Up More Than 100% From 2023, Net Income for the Year of $12.8 million is Up $21.0 Million from Prior Year ANDOVER, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today reported select financial results for its fiscal fourth quarter (“Q4 2024”) and full year ended November 30, 2024. Fiscal Fourth Quarter 2024 and Recent Operational HighlightsSurpassed 500,000 launchers sold since inception, just five and a half years after the sale of Byrna’s first launcher in June 2019. Increased launcher production in the first fiscal quarter of 2025 by 33% to 24,000 launchers a month to meet...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.